Home Blog Page 80

Blog

Pharma Marketing Blog

Most popular

PhRMA Rules Come Up Short

Pharma Guy - July 22, 2005

Celebrex Ad: Let’s Dive Deeper

Pharma Guy - April 5, 2007

Pre-emptive Drug Marketing?

Pharma Guy - May 3, 2006

Plan B FDAgate

Pharma Guy - November 15, 2005

#Pharma100: A Ludicrous, Leveraged Popularity Contest

Pharma Guy - July 17, 2013

GSK, National Headache Foundation and “Migraine Diary.” Is There an App...

Pharma Guy - May 2, 2011

Why Does GSK Prefer New York Physicians & Will Governor Patterson...

Pharma Guy - January 27, 2010

Your Aging Problem: Is It [LowT]? Take this Quiz and Find...

Pharma Guy - April 26, 2013

Out with the Bad, In with the Good

Pharma Guy - November 30, 2006

Pfizer’s Lipitor Co-pay Card/PBM Discount Plan Fails

Pharma Guy - May 2, 2012

1...798081...240 Page 80 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026